Literature DB >> 1686196

Human drug abuse liability assessment: opioids and analgesics.

G E Bigelow1.   

Abstract

Methods are described for assessment of the abuse liability of opioids and analgesics. The methods developed by the USPHS Addiction Research Center for assessment of opioid abuse liability have served as the prototype for most currently used abuse liability assessment approaches. The general method is that of comparing the profile of effects of a test drug to the profiles of placebo and of a known drug of abuse. Drugs with profiles of activity similar to the known drug of abuse are considered pharmacologically equivalent and of similar abuse liability. Specific methods, including the Addiction Research Inventory, adjective- and visual analog rating scales, are described, as are methodological developments that have been introduced to improve the sensitivity of the procedures and to adapt them to modern circumstances. It is concluded that the profile-of-effects methodology has proven extremely useful and should remain a basic element in abuse liability assessments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686196     DOI: 10.1111/j.1360-0443.1991.tb01756.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  6 in total

1.  Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: a randomized cross-over trial.

Authors:  Barth L Wilsey; Scott Fishman; Chin-Shang Li; Jeanna Storment; Anthony Albanese
Journal:  Pharmacol Biochem Behav       Date:  2009-08-04       Impact factor: 3.533

Review 2.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 3.  Principles of laboratory assessment of drug abuse liability and implications for clinical development.

Authors:  Lawrence P Carter; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

4.  Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.

Authors:  James P Zacny; Stephanie A Lichtor
Journal:  Psychopharmacology (Berl)       Date:  2007-09-27       Impact factor: 4.530

5.  Acute effects of tramadol in methadone-maintained volunteers.

Authors:  J Camí; X Lamas; M Farré
Journal:  Drugs       Date:  1994       Impact factor: 9.546

6.  Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study.

Authors:  Darren Wilbraham; Paul H Berg; Max Tsai; Emily Liffick; Li Shen Loo; Erin Gautier Doty; Edward Sellers
Journal:  J Clin Pharmacol       Date:  2019-11-20       Impact factor: 3.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.